The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Jump to: Company in focus,
Offsprings
Parent entities and officers
5
- 1
Cannon, Gillian Margaret
Born in November 1963Individual (4 offsprings)Officer2024-07-22 ~ nowOF - Director → CIF 0 - 2
Muhammed, Louwai, Dr
Born in December 1989Individual (3 offsprings)Officer2021-02-01 ~ nowOF - Director → CIF 0Dr Louwai Muhammed
Born in December 1989Individual (3 offsprings)Person with significant control2021-02-01 ~ 2022-05-16PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Right to appoint or remove directors → CIF 0 - 3
Elliott, Robert
Born in March 1982Individual (1 offspring)Officer2025-02-03 ~ nowOF - Director → CIF 0 - 4
Laaniste, Liisi, Dr
Born in October 1987Individual (1 offspring)Officer2021-02-01 ~ nowOF - Director → CIF 0Dr Liisi Laaniste
Born in October 1987Individual (1 offspring)Person with significant control2021-02-01 ~ 2022-05-16PE - Right to appoint or remove directors → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0 - 5
Johnson, Michael, Professor
Doctor born in April 1960Individual (1 offspring)Officer2021-02-01 ~ 2023-05-19OF - Director → CIF 0Professor Michael Johnson
Born in April 1960Individual (1 offspring)Person with significant control2021-02-01 ~ 2022-05-16PE - Right to appoint or remove directors → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Company in focus
COSYNE THERAPEUTICS LIMITED
Period: 2021-02-01 ~ now
Company number: 13171951
Registered name
COSYNE THERAPEUTICS LIMITED - now
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
212024-03-01 ~ 2025-02-28
172023-03-01 ~ 2024-02-29
Intangible Assets
113,149 GBP2025-02-28
221,117 GBP2024-02-29
Property, Plant & Equipment
62,314 GBP2025-02-28
75,520 GBP2024-02-29
Fixed Assets
175,463 GBP2025-02-28
296,637 GBP2024-02-29
Debtors
Current
889,423 GBP2025-02-28
621,154 GBP2024-02-29
Cash at bank and in hand
2,803,870 GBP2025-02-28
1,644,388 GBP2024-02-29
Current Assets
3,693,293 GBP2025-02-28
2,265,542 GBP2024-02-29
Creditors
Current, Amounts falling due within one year
-254,179 GBP2025-02-28
-283,490 GBP2024-02-29
Net Current Assets/Liabilities
3,439,114 GBP2025-02-28
1,982,052 GBP2024-02-29
Total Assets Less Current Liabilities
3,614,577 GBP2025-02-28
2,278,689 GBP2024-02-29
Creditors
Non-current, Amounts falling due after one year
-1,500,000 GBP2025-02-28
Net Assets/Liabilities
2,114,577 GBP2025-02-28
2,278,689 GBP2024-02-29
Equity
Called up share capital
64 GBP2025-02-28
54 GBP2024-02-29
Share premium
9,484,999 GBP2025-02-28
6,264,438 GBP2024-02-29
Retained earnings (accumulated losses)
-7,370,486 GBP2025-02-28
-3,985,803 GBP2024-02-29
Equity
2,114,577 GBP2025-02-28
2,278,689 GBP2024-02-29
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
106,955 GBP2025-02-28
214,555 GBP2024-02-29
Computer software
8,076 GBP2025-02-28
8,076 GBP2024-02-29
Intangible Assets - Gross Cost
115,471 GBP2025-02-28
222,631 GBP2024-02-29
Intangible Assets - Accumulated Amortisation & Impairment
2,322 GBP2025-02-28
1,514 GBP2024-02-29
Intangible Assets - Increase From Amortisation Charge for Year
808 GBP2024-03-01 ~ 2025-02-28
Intangible Assets
Patents/Trademarks/Licences/Concessions
106,955 GBP2025-02-28
214,555 GBP2024-02-29
Property, Plant & Equipment - Gross Cost
Office equipment
20,437 GBP2025-02-28
5,629 GBP2024-02-29
Computers
123,520 GBP2025-02-28
126,021 GBP2024-02-29
Property, Plant & Equipment - Gross Cost
143,957 GBP2025-02-28
131,650 GBP2024-02-29
Property, Plant & Equipment - Other Disposals
Computers
-6,748 GBP2024-03-01 ~ 2025-02-28
Property, Plant & Equipment - Other Disposals
-6,748 GBP2024-03-01 ~ 2025-02-28
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Office equipment
3,926 GBP2024-02-29
Computers
52,204 GBP2024-02-29
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
56,130 GBP2024-02-29
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Owned/Freehold
32,261 GBP2024-03-01 ~ 2025-02-28
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Computers
-6,748 GBP2024-03-01 ~ 2025-02-28
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-6,748 GBP2024-03-01 ~ 2025-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
6,517 GBP2025-02-28
Computers
75,126 GBP2025-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
81,643 GBP2025-02-28
Property, Plant & Equipment
Office equipment
13,920 GBP2025-02-28
1,703 GBP2024-02-29
Computers
48,394 GBP2025-02-28
73,817 GBP2024-02-29
Other Debtors
Current
168,185 GBP2025-02-28
153,772 GBP2024-02-29
Prepayments/Accrued Income
Current
80,446 GBP2025-02-28
57,813 GBP2024-02-29
Amount of corporation tax that is recoverable
Current
640,792 GBP2025-02-28
409,569 GBP2024-02-29
Bank Overdrafts
Current
6,517 GBP2024-02-29
Trade Creditors/Trade Payables
Current
107,677 GBP2025-02-28
225,868 GBP2024-02-29
Taxation/Social Security Payable
Current
54,662 GBP2025-02-28
1,561 GBP2024-02-29
Other Creditors
Current
23,189 GBP2025-02-28
8,138 GBP2024-02-29
Accrued Liabilities/Deferred Income
Current
68,651 GBP2025-02-28
41,406 GBP2024-02-29
Creditors
Current
254,179 GBP2025-02-28
283,490 GBP2024-02-29
Other Remaining Borrowings
Non-current
1,500,000 GBP2025-02-28
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2,444,171 shares2025-02-28
2,444,171 shares2024-02-29
Par Value of Share
Class 1 ordinary share
0.000012024-03-01 ~ 2025-02-28
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
2,268,703 shares2025-02-28
2,268,703 shares2024-02-29
Par Value of Share
Class 2 ordinary share
0.000012024-03-01 ~ 2025-02-28
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
688,125 shares2025-02-28
688,125 shares2024-02-29
Par Value of Share
Class 3 ordinary share
0.000012024-03-01 ~ 2025-02-28
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
968,136 shares2025-02-28
Par Value of Share
Class 4 ordinary share
0.000012024-03-01 ~ 2025-02-28
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
58,800 GBP2025-02-28
- Registered number 13171951
COSYNE THERAPEUTICS LIMITED
Info2 Sheraton Street, Wework Medius House, London W1F 8BHPRIVATE LIMITED COMPANY incorporated on 2021-02-01 (5 years 2 months). The status of the company number is Active.The last date of confirmation statement was made at 2026-01-31CIF 0
Offspring entities and appointments
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 22 March 2026 and
licensed under the Open Government Licence v3.0.